Emergent BioSolutions Operating Cash Flow 2011-2026 | EBS

Annual Operating Cash Flow Emergent BioSolutions

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-206 M	-34.1 M	320 M	537 M	188 M	41.8 M	208 M	54.6 M	42.5 M	112 M	97 M	39.6 M	12.2 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
537 M	-206 M	109 M

Quarterly Operating Cash Flow Emergent BioSolutions

2023-Q3	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-37.3 M	-	-	-	5.1 M	-	291 M	186 M	57.8 M	-	65.9 M	69 M	105 M	-	208 M	33.6 M	-1 M	-	131 M	95.7 M	41.7 M	-	67.3 M	40.2 M	-	-	-	-	-65.9 M	-	60.5 M	-18.4 M	-29.2 M	-	88.3 M	28.2 M	-4.63 M	-	78.7 M	32.2 M	13.8 M	-	-24.7 M	-29.4 M	-22.7 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
291 M	-65.9 M	50.5 M

Operating Cash Flow of other stocks in the Drug manufacturers industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
Aurora Cannabis ACB	-211 M	$ 3.53	2.32 %	$ 86.3 M	Canada
Alimera Sciences ALIM	-14.3 M	-	-	$ 142 M	USA
Adamis Pharmaceuticals Corporation ADMP	-25.9 M	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	-99.2 M	-	-	$ 754 M	USA
AcelRx Pharmaceuticals ACRX	-12.7 M	-	7.5 %	$ 6.35 M	USA
Canopy Growth Corporation CGC	-166 M	$ 1.07	4.9 %	$ 115 M	Canada
Agile Therapeutics AGRX	-9.58 M	-	10.11 %	$ 58.2 M	USA
Assertio Holdings ASRT	-28.2 M	$ 12.5	6.2 %	$ 80 M	USA
DURECT Corporation DRRX	-34.4 M	-	-	$ 50.1 M	USA
Avadel Pharmaceuticals plc AVDL	-46.9 M	-	-	$ 2.06 B	France
Eagle Pharmaceuticals EGRX	50.7 M	-	-39.89 %	$ 27.7 M	USA
Evolus EOLS	-42.3 M	$ 4.91	-2.58 %	$ 317 M	USA
Evoke Pharma EVOK	-4.98 M	-	-	$ 36.6 M	USA
Calliditas Therapeutics AB (publ) CALT	-462 M	-	-0.1 %	$ 2.03 B	Schweden
HEXO Corp. HEXO	-43.1 M	-	2.45 %	$ 38.1 M	Canada
Catalent CTLT	268 M	-	-	$ 11.5 B	USA
Cumberland Pharmaceuticals CPIX	-612 K	$ 3.01	-1.63 %	$ 42.3 M	USA
Jupiter Wellness JUPW	-7.57 M	-	-	$ 33.6 M	USA
Athenex ATNX	-131 M	-	-23.39 %	$ 1.76 M	USA
Endo International plc ENDP	435 M	-	-	$ 28.9 M	Irlanda
Organogenesis Holdings ORGO	14.2 M	$ 2.53	-1.94 %	$ 333 M	USA
Harrow Health HROW	43.9 M	$ 35.23	0.92 %	$ 1.3 B	USA
Pacira BioSciences PCRX	189 M	$ 21.94	-3.31 %	$ 1.01 B	USA
OrganiGram Holdings OGI	-28.6 M	$ 1.43	0.7 %	$ 402 M	Canada
China Pharma Holdings CPHI	-466 K	$ 0.61	-1.52 %	$ 10.7 M	China
Sundial Growers SNDL	-155 M	$ 1.44	-	$ 3.37 M	Canada
Veru VERU	-21.7 M	$ 2.41	1.69 %	$ 325 M	USA
ProPhase Labs PRPH	28.6 M	-	-	$ 5.07 M	USA
TherapeuticsMD TXMD	-159 M	$ 2.23	2.76 %	$ 23.3 M	USA
Lannett Company LCI	-7.12 M	-	1.15 %	$ 7.11 M	USA
Radius Health RDUS	-22.4 M	-	-	$ 1.42 B	USA
Viatris VTRS	2.9 B	$ 13.8	2.15 %	$ 16.6 B	USA
Perrigo Company plc PRGO	238 M	$ 10.3	5.86 %	$ 1.43 B	USA
Neoleukin Therapeutics NLTX	-51.4 M	-	-	$ 193 M	Canada
Sonoma Pharmaceuticals SNOA	-88 K	$ 2.4	-0.41 %	$ 2.98 M	USA
Relmada Therapeutics RLMD	-51.7 M	$ 6.45	4.37 %	$ 194 M	USA
Rockwell Medical RMTI	-9.41 M	$ 1.06	10.96 %	$ 24.7 M	USA
PetIQ PETQ	61.9 M	-	1.64 %	$ 400 M	USA
OptiNose OPTN	-20.5 M	-	-	$ 1.08 B	USA
PLx Pharma PLXP	-32.1 M	-	-27.8 %	$ 2.56 M	USA
SCYNEXIS SCYX	-5.28 M	$ 0.92	2.39 %	$ 45.9 M	USA
Recro Pharma REPH	-1 M	-	-4.76 %	$ 65.3 M	USA
Solid Biosciences SLDB	-100 M	$ 7.76	3.74 %	$ 317 M	USA
Tilray TLRY	7.91 M	$ 6.95	0.72 %	$ 4.29 B	Canada
Tricida TCDA	-140 M	-	-	$ 3.25 M	USA
cbdMD YCBD	-353 K	$ 0.75	4.53 %	$ 3.23 M	USA
Zynerba Pharmaceuticals ZYNE	-23 M	-	-	$ 55.5 M	USA
Zomedica Corp. ZOM	-17.6 M	-	-0.21 %	$ 98 M	USA